OTCM
SWDCF
Market cap303mUSD
Jan 11, Last price
6.51USD
Name
Swedencare AB (publ)
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Swedencare AB (publ), an enterprise established in 1993 and headquartered in Malmö, Sweden, operates with its subsidiaries to develop, produce, market, and sell a wide array of healthcare products, predominantly for animals. The company's flagship offering is the ProDen PlaqueOff line, focused on dental hygiene for dogs and cats. This popular range includes a food supplement powder designed to reduce plaque and tartar buildup, along with various chewable formats such as dental bites, bones (including mini versions for smaller dogs), and soft chews suitable for both felines and canines. Beyond dental care, Swedencare provides an extensive selection of nutritional supplements under the NutriScience brand for cats, dogs, and horses. These products address diverse health requirements: Glucosamine and Stomax aid in the rejuvenation of joint cartilage, bones, muscles, ligaments, and sinews; ArthriAid supports joint function and mobility; KalmAid offers a calming effect for anxious dogs; while OmegaAid and RevitalAid are formulated to promote healthy skin and coats. Furthermore, the company manufactures specialized supplements for horses, including Gastrocare to alleviate gastric pain and enhance appetite; Equine Gold for overall vitality; a horse-specific ArthriAid to assist with cartilage formation; and AnxiKalm, aimed at soothing excitable horses. Interestingly, Swedencare also caters to human health with ProDen PlaqueOff Teeth and Gums, a natural dietary supplement designed to boost oral hygiene and prevent tartar accumulation. The company's products are distributed through a broad network that includes pharmacies, veterinary clinics, pet stores, animal hospitals, and online channels.
Key people
Hakan Svanberg
Chairman of the Board · since 2022
Hakan Lagerberg
Chief Executive Officer · since 2022
Jenny Graflind
Chief Financial Officer · since 2020
Tim Ackerman
Chief Executive Officer - Fulfillment Advantage Ventures Inc · since 2021
Lynn Bowgren
Chief Executive Officer - Rx Vitamins Inc. · since 2023
Geoff Granger
Chief Executive Officer - NaturVet · since 2023
Ed Holden
Chief Executive Officer - Pet MD Brands LLC · since 2021
Chris Jones
Chief Executive Officer - Nutravet UK Ltd · since 2024
John Leonard
Chief Executive Officer - Swedencare UK Ltd and Swedencare Ireland · since 2019
David Ryder
Chief Executive Officer - Custom Vet Products Ltd · since 2022
Martin Shimko
Chief Executive Officer - Swedencare USA Inc. and Swedencare Tillverka Inc · since 2022
Brian Thomas
Chief Executive Officer - MedVant Inc. · since 2024
Renato Valle
Chief Executive Officer - Innovet Italia SRL
Manuel Aguiar
General Manager - Vetio South · since 2023
Loiec Dufour
Country Manager - Swedencare France SARL · since 2021
Alain Dugal
General Manager - Vetio North · since 2023
John Kane
Production Director · since 2023
Brian Nugent
Commercial Officer - North America · since 2023
Ioanna Psychogiou
Country Manager - Biovet I.K.E · since 2021
Raquel Tosca
Country Manager - Swedencare Spain SLU · since 2019
Headquarters & legal address
C/O Medeon Science Park
Per Albin Hanssons v.41
Malmö, M 205 12
SE
Per Albin Hanssons v.41
Malmö, M 205 12
SE
Address
C/O Medeon Science Park
Per Albin Hanssons v.41
Malmo, M 205 12
SE
Per Albin Hanssons v.41
Malmo, M 205 12
SE
Previous name
SDC SweDenCare AB
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||